SheebaKoshy(Koshy)ThomasMD

PubMed

• Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
  Oren Pasvolsky, Sassine Ghanem, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guilin Tang...> ;Blood Cancer Journal. 2024 Jan 10
• Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem c...
  Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C Lee,...> ;Cancer. 2023 Dec 21
• Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.
  Saini, N., Becnel, M., Amini, B., Lin, P., Dabaja, B., Fang, P., Pinnix, C., Wu, S., Lee, H., Patel, K., Kaufman, G., Thomas, S., Orlowski, R., Gunther, J.> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Dec 8
• Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
  Oren Pasvolsky, Denái R Milton, Adeel Masood, Sophiya S Sami, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Arsalan Sa...> ;American Journal of Hematology. 2023 Oct 1
• First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
  Larry Kwak, Szymon Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottham, Sheetal Ra...> ;Research Square. 2023 Sep 21
• Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.
  Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C Lee, Krina K Pate...> ;British Journal of Haematology. 2023 Aug 1
• 6 citations
  Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
  Minghao Dang, Ruiping Wang, Hans C Lee, Krina K Patel, Melody R Becnel, Guangchun Han, Sheeba K Thomas, Dapeng Hao, Yanshuo Chu, Donna M Weber, Pei Lin, Zuzana Lutter-...> ;Cancer Cell. 2023 Jun 12
• 2 citations
  Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors.
  Chia-Yu Chiu, Sairah Ahmed, Sheeba K Thomas, Lan Sun Wang, Khalis Mustafayev, Luis E Fayad, William G Wierda, Fareed Khawaja, Harrys A Torres> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Aug 1
• 6 citations
  Report of consensus panel 1 from the 11International Workshop on Waldenstrom's Macroglobulinemia on management of symptomatic, treatment-naïve patients.
  Christian Buske, Jorge J Castillo, Jithma Prasad Abeykoon, Ranjana Advani, Suzanne O Arulogun, Andrew R Branagan, Xinxin Cao, Shirley D'Sa, Jian Hou, Prashant Kapoor, ...> ;Seminars in Hematology. 2023 Mar 1
• 2 citations
  Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
  Oren Pasvolsky, Rima M Saliba, Adeel Masood, Ali H Mohamedi, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Hans C Lee, Krina K P...> ;British Journal of Haematology. 2023 May 1
• 4 citations
  Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.
  Oren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, Adeel Masood, Sophiya S Sami, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, G...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma.
  Ethan P Damron, Muzaffar H Qazilbash, Penny Q Fang, Susan Y Wu, Bouthaina S Dabaja, Gabriela Rondon, Chitra Hosing, Richard E Champlin, Qaiser Bashir, Elizabeth J Shpa...> ;Transplantation and Cellular Therapy. 2023 Jan 1
• 2 citations
  Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple M...
  B R Shank, B Primeaux, E K Yeung, S B Horowitz, I Y Lee, L Roccograndi, L Feng, G P Kaufman, H C Lee, E E Manasanch, K K Patel, R Z Orlowski, D M Weber, M R Becnel, S ...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Apr 1
• 3 citations
  Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies.
  Chia-Yu Chiu, Krina Patel, Sheeba K Thomas, Fareed Khawaja, Natalie J M Dailey Garnes, Hans C Lee, Maro Ohanian, Ying Jiang, Lan S Wang, Jessica P Hwang, Harrys A Torres> ;Hepatology International. 2023 Apr 1
• 3 citations
  Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms.
  Okechukwu V Nwogbo, L Jeffrey Medeiros, Beenu Thakral, Shaoying Li, Jie Xu, M James You, Wei Wang, Andres E Quesada, Carlos Bueso Ramos, Timothy J McDonnell, Sheeba K ...> ;Human Pathology. 2022 Dec 1
• 3 citations
  Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma.
  Oren Pasvolsky, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Guilin Tang, Neeraj Saini, Jeremy Ramdial, Adeel Masood, Yago Nieto, Hans C Lee...> ;Transplantation and Cellular Therapy. 2022 Nov 1
• 3 citations
  Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
  Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal...> ;American Journal of Hematology. 2022 Jul 1
• 1 citations
  Impact of Induction With VCD Versus VRD on the Outcome of Patients With Multiple Myeloma After an Autologous Hematopoietic Stem Cell Transplantation.
  Aimaz Afrough, Oren Pasvolsky, Junsheng Ma, Samer Srour, Qaiser Bashir, Neeraj Saini, Chitra Hosing, Uday R Popat, Partow Kebriaei, Ruby Delgado, Muhammad R Ullah, Reg...> ;Transplantation and Cellular Therapy. 2022 Jun 1
• Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma.
  Aimaz Afrough, Leonard C Alsfeld, Denái R Milton, Ruby Delgado, Uday R Popat, Yago Nieto, Partow Kebriaei, Betul Oran, Neeraj Saini, Samer Srour, Chitra Hosing, Faisal...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 7 citations
  KRD vs. VRD as induction before autologous hematopoietic progenitor cell transplantation for high-risk multiple myeloma.
  Mahmoud R Gaballa, Junsheng Ma, Mikael Rauf, Roland Bassett, Oren Pasvolsky, Mark R Tanner, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Reg...> ;Bone Marrow Transplantation. 2022 Jul 1
• 4 citations
  Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma.
  Krina K Patel, Jatin J Shah, Lei Feng, Hans C Lee, Elisabet M Manasanch, Jasper Olsem, Ashley Morphey, Xiao Jiao Huo, Sheeba K Thomas, Qaiser Bashir, Muzaffar H Qazilb...> ;Clinical Cancer Research. 2022 Apr 1
• 4 citations
  Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions
  Sheeba K. Thomas> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Nov 1
• 8 citations
  Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance
  Mahmoud R Gaballa, Junsheng Ma, Mark R Tanner, Taha Al-Juhaishi, Qaiser Bashir, Samer A Srour, Neeraj Saini, Jeremy L Ramdial, Yago Nieto, Regan Murphy, Katayoun Rezva...> ;Leukemia & Lymphoma. 2021 Oct 22
• 3 citations
  Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to whites: a propensity-score matched analysis
  Romil Patel, Junsheng Ma, Qaiser Bashir, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Chitra Hosing, Yago Nieto, Partow Kebriaei, Amin M. Alousi, May Daher, Rohtesh S...> ;American Journal of Hematology. 2021 Sep 24
• 8 citations
  Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.
  Samer A. Srour, Denái R. Milton, Qaiser Bashir, Yago Nieto, Neeraj Saini, May Daher, Jeremy Ramdial, Jin Im, Chitra Hosing, Ruby Delgado, Elisabet E. Manasanch, Hans C...> ;Haematologica. 2021 Aug 19
• Join now to see all

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
• Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191  
  Sheeba K Thomas, Robert Z Orlowski, Hans C Lee, Clinical Cancer Research
• Phase I Study of an Active Immunotherapy for Asymptomatic Phase Lymphoplasmacytic Lymphoma with DNA Vaccines Encoding Antigen-Chemokine Fusion: Study Protocol  
  Sattva S Neelapu, D Lynne Smith, Vincent Y Lee, Larry W Kwak, Sheeba K Thomas, BioMed Central

Abstracts/Posters

• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Preliminary Safety and Anti-Tumor Activity of XmAb13676, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Non-HodgkinÍs Lymphoma and C...
  Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Sheeba K. Thomas, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Phase I trial of a novel DNA vaccine in patients (pts) with smoldering Waldenstrom macroglobulinemia (sWM). 
  2019 ASCO Annual Meeting - 6/1/2019
• Older Age As a Prognostic Factor for Overall Survival for Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Outcome of Autologous Stem Cell Transplantation in Waldenström's Macroglobulinemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Updated Results of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myel... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all